Haematologica Reports 2005; 1(issue 9): 1[prev][index][next]

The scale of the problem
Prins MH
Department of Clinical Epidemiology and Medical Technology Assessment, Academic Hospital Maastricht, The Netherlands

It is generally accepted that patients with active malignancy are prone to develop venous thromboembolic disease. Factors that are thought to contribute to the increased risk of venous thrombosis in these patients, include procoagulant effects of cancer cells themselves or caused by their interaction with the host environment, chemotherapeutic drugs, surgery and immobility. [>Read full article in PDF]